The Supreme Court, Medication Abortion, and the FDA: What’s at Stake?

In advance of oral arguments about access to medication abortion before the Supreme Court on March 26, KFF examines how a Court ruling for the plaintiffs would limit access to mifepristone blocking its use in telehealth and distribution through pharmacies, including in states where abortion is legal and protected. In addition, it could potentially weaken…More

from KFF https://ift.tt/6pfS1Zl